NPCE

NeuroPace

Stock NASDAQ – Stock Market Prices, News & Analysis

NeuroPace Inc is a medical technology company dedicated to developing solutions for epilepsy using implantable neurostimulator devices.

$ 14.07
7.00 %

NeuroPace

$ 14.07
7.00 %
NPCE

NeuroPace Inc is a medical technology company dedicated to developing solutions for epilepsy using implantable neurostimulator devices.

Price history of NeuroPace
Price history of NeuroPace

Performance & Momentum

6 Months 34.90 %
1 Year 3.91 %
3 Years 190.10 %
5 Years 44.69 %

Strategic Analysis

NeuroPace • 2026

NeuroPace positions itself as an innovative player in the medical technology sector, specializing in implantable devices for the treatment of epilepsy. Its model is based on advanced neurostimulative technology, addressing a therapeutic niche with high growth potential through the continuous improvement of its medical solutions.

Strengths
  • Proprietary neurostimulation technology offering a non-drug alternative for the treatment of epilepsy
  • Strong historical growth demonstrating a gradual adoption of its devices
  • Positioned in an expanding healthcare market with a genuine unmet need
Weaknesses
  • Dependence on a niche market with high regulatory barriers
  • Volatility of long-term performance affected by investment and development phases
Momentum

The very positive momentum reflects a growing interest from investors, supported by strong operational results and favorable adoption dynamics. This indicates enhanced valuation potential in the medium term, although the company still needs to prove its ability to stabilize profitability.

Analysis performed 1 month ago

Similar stocks to NeuroPace

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone